Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism CSF-1R antagonists(Colony stimulating factor 1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization AmMax Bio, Inc.Startup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 2 | US | 10 Dec 2024 | |
Colorectal Cancer | Phase 2 | US | AmMax Bio, Inc.Startup | 10 Dec 2024 |
Residual Neoplasm | Phase 2 | US | 10 Dec 2024 | |
Residual Neoplasm | Phase 2 | US | AmMax Bio, Inc.Startup | 10 Dec 2024 |